Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction.
